In fact, ALDH1A1 inhibition does sensitize colon, breast, pancreas, and ovarian cancer cells to chemotherapy [45,46,47,48], but further evidence is needed to conclusively determine whether this is also the case in AML. Here, ALDH1A1 is linked to ovarian carcinoma.